Abstract
Fresh and frozen-stored mitochondrial, microsomal, and endoplasmic reticulum extracts of blood leucocytes act as potent alloantigens in human recipients. Similar results were obtained with freshly prepared extracts consisting of mixtures of all cytoplasmic fractions; storage of such mixtures at--20 C, followed by 1-2 hr thawing at 37 C abrogated their capacity to induce allograft sensitivity in 45 of 47 recipients. Donor-specific skin allografts and grafts from other sources exhibited significant attenuations in the tempo and intensity of rejection, ranging from first-set rejection to chronic rejection and/or to prolongations in allograft survival. In contrast with the 66.2% rejection rate of first-set skin grafts at 10 days in 71 normal subjects, only 29% of skin grafts from the leucocyte donor applied to 24 recipients of 0.1 to 9 Transplantation Antigen (T.A.) units of pooled cytoplasmic mixtures were rejected by that time. Only 17.4% similar grafts in 23 recipients of 25 to 515 T.A. units were rejected at 10 days. Seventeen skin grafts placed on recipients of 45 to 140 T.A. units of the same cytoplasmic preparation exhibited a slow rejection characterized by progressive shrinkage and eventual disappearance, with no evidence of hemorrhagic necrosis (chronic skin graft rejection). These results support the possibility that the attenuations in allograft reactivity observed in patients with end-stage renal disease after blood transfusions may be related to the leucocyte components of such transfusions. The capacity of blood transfusions to decrease reactivity to renal allografts in uremic patients maintained on hemodialysis stands in contrast with the ability of such transfusions to sensitize normal human recipients to donor-specific skin allografts. The differential effect may be related to the immunosuppressed state(s) documented in the uremic population, and/or the use of immunosuppressive drug therapy in such patients at the time of transplantation and thereafter.
Full text
PDF







Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bachvaroff R. J., Ayvazian J. H., Skupp S., Rapaport F. T. Specific restriction endonuclease degradation of DNA as a consequence of immunologically mediated cell damage. Transplant Proc. 1977 Mar;9(1):807–812. [PubMed] [Google Scholar]
- Brent L., Horsburgh T., Wood P. J. Induction of suppressor cells and allograft tolerance. Transplant Proc. 1980 Sep;12(3):464–472. [PubMed] [Google Scholar]
- CONVERSE J. M., RAPAPORT F. T. The vascularization of skin autografts and homografts; an experimental study in man. Ann Surg. 1956 Mar;143(3):306–315. doi: 10.1097/00000658-195603000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DAMMIN G. J., COUCH N. P., MURRAY J. E. Prolonged survival of skin homografts in uremic patients. Ann N Y Acad Sci. 1957 Mar 22;64(5):967–976. doi: 10.1111/j.1749-6632.1957.tb52488.x. [DOI] [PubMed] [Google Scholar]
- Dausset J., Contu L., Legrand L., Marcelli-Barge A., Meo T., Rapaport F. T. Role of Ia-like products of the main histocompatibility complex in conditioning skin allograft survival in man. J Clin Invest. 1979 May;63(5):893–901. doi: 10.1172/JCI109389. [DOI] [PMC free article] [PubMed] [Google Scholar]
- First International Symposium on the Role of Blood Transfusion in Transplantation. February 1-3, 1982, Los Angeles, California. Proceedings. Transplant Proc. 1982 Jun;14(2):247–423. [PubMed] [Google Scholar]
- LAWRENCE H. S., RAPAPORT F. T., CONVERSE J. M., TILLETT W. S. Transfer of delayed hypersensitivity to skin homografts with leukocyte extracts in man. J Clin Invest. 1960 Jan;39:185–198. doi: 10.1172/JCI104018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leivestad T., Flatmark A., Hirschberg H., Thorsby E. Effect of pretransplant donor-specific transfusions in renal transplantation. Transplant Proc. 1982 Jun;14(2):370–373. [PubMed] [Google Scholar]
- Lenhard V., Massen G., Seifert P., Johannsen R., Grosse-Wilde H. Characterization of transfusion-induced suppressor cells in prospective kidney allograft recipients. Transplant Proc. 1982 Jun;14(2):329–332. [PubMed] [Google Scholar]
- Maki T., Okazaki H., Wood M. L., Monaco A. P. Suppressor cells in mice bearing intact skin allografts after blood transfusions. Transplantation. 1981 Dec;32(6):463–466. doi: 10.1097/00007890-198112000-00002. [DOI] [PubMed] [Google Scholar]
- Oh J. H., McClure H. M., Galvao M. M. Comparison of immunogenicity of fresh and stored blood. A study in rhesus monkeys. Transplantation. 1982 Feb;33(2):198–200. doi: 10.1097/00007890-198202000-00018. [DOI] [PubMed] [Google Scholar]
- RAPAPORT F. T., CONVERSE J. M. Observations on immunological manifestations of the homograft rejection phenomenon in man: the recall flare. Ann N Y Acad Sci. 1957 Mar 22;64(5):836–841. doi: 10.1111/j.1749-6632.1957.tb52477.x. [DOI] [PubMed] [Google Scholar]
- RAPAPORT F. T., CONVERSE J. M. The immune response to multiple-set skin homografts: an experimental study in man. Ann Surg. 1958 Mar;147(3):273–280. doi: 10.1097/00000658-195803000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- RAPAPORT F. T., DAUSSET J., CONVERSE J. M., LAWRENCE H. S. BIOLOGICAL AND ULTRASTRUCTURAL STUDIES OF LEUCOCYTE FRACTIONS AS TRANSPLANTATION ANTIGENS IN MAN. Transplantation. 1965 Jul;3:490–500. doi: 10.1097/00007890-196507000-00004. [DOI] [PubMed] [Google Scholar]
- RAPAPORT F. T., LAWRENCE H. S., THOMAS L., CONVERSE J. M., TILLETT W. S., MULHOLLAND J. H. Cross-reactions to skin homografts in man. J Clin Invest. 1962 Dec;41:2166–2172. doi: 10.1172/JCI104675. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rapaport F. T., Bachvaroff R. J., Akiyama N., Sato T., Ferrebee J. W. Specific allogeneic unresponsiveness in irradiated dogs reconstituted with autologous bone marrow. Transplantation. 1980 Jul;30(1):23–30. doi: 10.1097/00007890-198007000-00005. [DOI] [PubMed] [Google Scholar]
- Rapaport F. T., Dausset J., Lawrence H. S., Converse J. M. An approach to the facilitation of skin allograft survival in man. Surg Forum. 1966;17:198–199. [PubMed] [Google Scholar]
- Salvatierra O., Jr Experiences and future considerations with donor-specific blood transfusions in living-related transplantation. Am J Kidney Dis. 1981 Sep;1(2):119–124. doi: 10.1016/s0272-6386(81)80041-8. [DOI] [PubMed] [Google Scholar]
- Sasportes M., Carosella E., Bensussan A., Mihaesco C., Dausset J. Regulation of the human allogenic proliferative response in vitro. II. Production of soluble suppressor factors by suppressor T cells and evidence in favor of "acceptor" cells for suppression among unprimed lymphocytes. Immunogenetics. 1981;14(1-2):117–127. doi: 10.1007/BF00344305. [DOI] [PubMed] [Google Scholar]
- Sasportes M., Fradelizi D., Dausset J. HLA-DR specific human suppressor lymphocytes generated by repeated in vitro sensitisation against allogeneic cells. Nature. 1978 Nov 30;276(5687):502–504. doi: 10.1038/276502a0. [DOI] [PubMed] [Google Scholar]
- Slavin S., Strober S., Fuks Z., Kaplan H. S. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J Exp Med. 1977 Jul 1;146(1):34–48. doi: 10.1084/jem.146.1.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wood P., Horsburgh T., Brent L. Specific unresponsiveness to skin allografts in mice. VI. Graft survival in mice pretreated with blood. Transplantation. 1981 Jan;31(1):8–14. doi: 10.1097/00007890-198101000-00003. [DOI] [PubMed] [Google Scholar]




